Skip to content

In-office and Domiciliary Use of a New Ozonized Gel for the Management of Periodontal Disease

Evaluation of a New In-office and Domiciliary Ozonized Gel for the Management of Periodontal Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05254288
Enrollment
30
Registered
2022-02-24
Start date
2022-03-22
Completion date
2022-10-19
Last updated
2022-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Diseases

Keywords

ozone, chlorhexidine, split-mouth

Brief summary

The aim of this study is to evaluate the efficacy of non-surgical periodontal therapy with supportive home oral care for the treatment of periodontal disease. Patients with bilateral periodontal pathological sites will undergo professional dental hygiene with ultrasonic handpiece (Piezon EMS with PerioSlim inserts) followed by manual instrumentation with Gracey curettes and application of erythritol Airflow powders. Then, patients will be randomly divided into two groups according to a split-mouth design: the Control Group will undergo a split-mouth application of chlorhexidine gel 1% for quadrants 1/3 (or 2/4), while for the Trial Group Ozoral Pro for quadrants 2/4 (or 1/3) will be used. Patients will use the products at home with one daily application for the following 14 days after the visits. The Trial Group will use Ozoral Gel for home applications. The following indexes will be assessed at baseline, T1 (1 month), T2 (3 months) and T3 (6 months): recession, PPD, BoP %, CAL, PCR %. Contextually, the application of the two gels will be performed.

Detailed description

The aim of this study is to evaluate the efficacy of non-surgical periodontal therapy with supportive home oral care for the treatment of periodontal disease comparing chlorhexidine and ozone gels. Patients with bilateral periodontal pathological sites will undergo professional dental hygiene with ultrasonic handpiece (Piezon EMS with PerioSlim inserts) followed by manual instrumentation with Gracey curettes and application of erythritol Airflow powders. Then, patients will be randomly divided into two groups according to a split-mouth design: * Control Group: application of chlorhexidine gel 1% for quadrants 1/3 (or 2/4) * Trial Group: administration of Ozoral Pro for quadrants 2/4 (or 1/3). Patients will use the products at home with one daily application for the following 14 days after the visits. The Trial Group will use Ozoral Gel for home applications. The following indexes will be assessed at baseline, T1 (1 month), T2 (3 months) and T3 (6 months): recession, PPD, BoP %, CAL, PCR %. Contextually, the application of the two gels will be performed.

Interventions

OTHERChlorhexidine

In-office and domiciliary use of chlorhexidine for 14 days.

OTHEROzoral gels

In-office administration of Ozoral Pro and domiciliary use of Ozoral gel for 14 days.

Sponsors

University of Pavia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Gels concealed

Intervention model description

Split-mouth

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Presence of bilateral periodontal sites according to the new Classification of Periodontal and Peri-implant Diseases (Severity: Staging I; Complexity: Staging II). * No systemic disease; * Compliant patients.

Exclusion criteria

* Absence of dental implants; * Neurological and psychiatric diseases; * Patients taking bisphosphonates during the previous 12 months from the beginning of the study; * Pregnant and/or breastfeeding women; * Patients undergoing anticancer therapy. * Patients with poor compliance.

Design outcomes

Primary

MeasureTime frameDescription
Change in R - Gingival recessionTime Frame: baseline, 1, 3 and 6 months after baselineDistance (in mm) between the gingival margin and the amelo-cemental junction.
Change in PPD - Probing Pocket DepthTime Frame: baseline, 1, 3 and 6 months after baselineEvaluation (in mm) of the depth of the gingival sulcus, through a millimeter periodontal probe; it is detected from the gingival margin to the bottom of the gingival sulcus or periodontal pocket, evaluated at 6 sites.
Change in Bleeding on Probing (BOP%)Time Frame: baseline, 1, 3 and 6 months after baselineDichotomous scoring (yes/no) of bleeding sites
Change in Plaque Control Record (PCR%)Time Frame: baseline, 1, 3 and 6 months after baseline% assessment of the amount of plaque on dental surfaces; it is detected on 4 surfaces: distal, mesial, vestibular, lingual / palatal. The number of sites with plaque is divided by the total number of sites available in the mouth and multiplied by 100. Results indicate the index as a percentage.
Change in Dental mobility (Miller, 1985)Time Frame: baseline, 1, 3 and 6 months after baselineScoring criteria * Grade 0: oscillation within 0.2 mm; the teeth move naturally and there are no mobility problems; * Grade I: horizontal mobility of the tooth from 0.2 to 1 mm; * Grade II: horizontal mobility of the tooth from 1 to 2 mm; * Grado III: horizontal mobility equal to or greater than 3 mm or vertical mobility of the tooth.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026